We are glad to inform that we have obtained the MA for our Fampridine 10 mg prolonged-released tablets in Spain, The Netherlands and France, through DCP.

Please contact us at info@intasb2b.com for more information.

To view region specific filing plan and available MAs, click the relevant link below.
http://intasportfolio.com/

Published on December 16, 2020